[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Legal Cannabis Market Size & Share to Record New Values for the Forecast Period 2020-2030

May 2024 | 157 pages | ID: N9FE77157C0BEN
Fatpos Global

US$ 5,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Overview
Cannabis is a synthetic drug produced from the dried leaves and flowers of the hemp plant, which thrives in tropical and temperate climates across the world. Cannabis, also known as hash, weed, marijuana, pot, dope, smoke, and cone, can be obtained in a variety of ways, ranging from the basic process of drying and curing marijuana flowers to the complex chemistry involved in manufacturing cannabis concentrates. Cannabis is gaining popularity for both medical and recreational reasons in North America as the legal landscape shifts toward decriminalization and complete legalization. Marijuana has been legalized in 30 states for medicinal reasons and 9 states for both therapeutic and recreational use in the United States. The use of the substance for therapeutic purposes has been lawful in Canada since 2001; nevertheless, recreational use was made possible by a bill enacted in June 2018. This shift in the regulatory environment has resulted in more people using medicinal cannabis to address conditions including chronic pain, depression, PTSD, social anxiety, cancer, multiple sclerosis, and epilepsy, all of which are linked to changing lifestyles.

North America Legal Cannabis Market: Key Players
Canopy Growth Corporation

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Aphria, Inc.
Aurora Cannabis
Tilray
Organigram Holdings, Inc.
Lexaria Bioscience Corp.
ABcann Medicinals, Inc. (Part of Vivo Cannabis)
The Cronos Group
Wayland Group Corp. (Maricann Group Inc.)
CannTrust Holdings

Growth Factor
Increasing legalization of cannabis and rise in social acceptance of marijuana
Cannabis legalization is frequently regarded in a dual perspective, with skepticism linked with the possibility of misuse. People may now use cannabis in a safe manner while also benefiting from its medical properties, thanks to its legalization. As a result, numerous nations throughout the world are increasingly legalizing the use of cannabis. While most nations throughout the world have yet to legalize cannabis for recreational use, attitudes toward its use and sale have been more relaxed over time. As a result, cannabis has become increasingly popular in numerous places, propelling the whole cannabis industry forward.

Increase in Cannabis- based Consumables.
Cannabis consumer goods firms and merchants are swiftly adapting to satisfy the demands of the “mainstream” cannabis customer. Customers may now choose from a growing number of goods, including concentrates, infused items, and topicals, in addition to smoking flower via joints, pipes, or bongs. Products on the market are progressively addressing the features that modern consumers desire, such as more discretion, convenience of use, product safety, and precise dosage. Companies have responded to these needs with increasingly complex packaging and advertising in order to attract more mainstream customers.

Segmentation
By Product Type
Flowers
Concentrates
Other product types (capsules, topicals, edibles, and beverages)
By Application
Medical
Recreational
By Compound
Tetrahydrocannabinol (THC)-dominant
Cannabidiol (CBD)-dominant
Balanced THC & CBD
North America Legal Cannabis Market Dynamics
North America Legal Cannabis Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Recent News Related to Market

In December 2020, Aphria Inc. and Tilray Inc. (Canada) signed a comprehensive deal to merge their operations and form the world's largest cannabis corporation. The combined company would have a comprehensive portfolio of branded Cannabis 2.0 products in Canada, supported by low-cost growing, processing, and manufacturing facilities.
In November 2020, Aphria Inc. completed the acquisition of SW Brewing Company, LLC (US), one of the leading independent craft brewers. SweetWater is a cannabis lifestyle brand that would help Aphria broaden its product offering.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the North America Legal Cannabis Market growth?
Which segment accounted for the largest North America Legal Cannabis Market share?
Who are the key players in the North America Legal Cannabis Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY

2. GLOBAL NORTH AMERICA LEGAL CANNABIS MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MACRO-ECONOMIC INDICATORS

6. MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9. RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. GLOBAL NORTH AMERICA LEGAL CANNABIS MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11. GLOBAL NORTH AMERICA LEGAL CANNABIS MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. NORTH AMERICA LEGAL CANNABIS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product Type: Market Share (2020-2030F)
  12.2.1. Flowers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Concentrates, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Other product types (capsules, topicals, edibles, and beverages), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Application: Market Share (2020-2030F)
  12.3.1. Medical, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Recreational, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Compound: Market Share (2020-2030F)
  12.4.1. Tetrahydrocannabinol (THC)-dominant, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.2. Cannabidiol (CBD)-dominant, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.3. Balanced THC & CBD, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13. COMPANY PROFILE

13.1. Canopy Growth Corporation
  13.1.1. Company Overview
  13.1.2. Company Total Revenue (Financials)
  13.1.3. Market Potential
  13.1.4. Global Presence
  13.1.5. Key Performance Indicators
  13.1.6. SWOT Analysis
  13.1.7. Product Launch
13.2. Aphria, Inc.
13.3. Aurora Cannabis
13.4. Tilray
13.5. Organigram Holdings, Inc.
13.6. Lexaria Bioscience Corp.
13.7. ABcann Medicinals, Inc. (Part of Vivo Cannabis)
13.8. The Cronos Group
13.9. Wayland Group Corp. (Maricann Group Inc.)
13.10. CannTrust Holdings
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications